Szerző szerinti böngészés "Buch, Maya H."
Megjelenítve 1 - 6 (Összesen 6)
Találat egy oldalon
Rendezési lehetőségek
Tétel Korlátozottan hozzáférhető 2024 EULAR Points to Consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer(2024) Sebbag, Eden; Lauper, Kim; Molina-Collada, Juan; Aletaha, Daniel; Askling, Johan; Gente, Karolina; Bertheussen, Heidi; Bitoun, Samuel; Bolek, Ertugrul Cagri; Burmester, Gerd R.; Canhão, Helena M.; Chatzidionysiou, Katerina; Curtis, Jeffrey R.; Danlos, Francois-Xavier; Guimarães, Vera; Hetland, Merete Lund; Iannone, Florenzo; Kostine, Marie; Kragstrup, Tue Wenzel; Kvien, Tore K.; Regierer, Anne Constanze; Schulze-Koops, Hendrik; Silva-Fernández, Lucía; Szekanecz, Zoltán; Buch, Maya H.; Finckh, Axel; Gottenberg, Jacques-EricTétel Szabadon hozzáférhető EULAR definition of difficult-to-treat rheumatoid arthritis(2021) Nagy, György; Roodenrijs, Nadia M. T.; Welsing, Paco M. J.; Kedves, Melinda; Hamar, Attila Béla; Goes, Marlies C. van der; Kent, Alison; Bakkers, Margôt; Blaas, Etienne; Senolt, Ladislav; Szekanecz, Zoltán; Choy, Ernest; Dougados, Maxime; Jacobs, Johannes W. G.; Geenen, Rinie; Bijlsma, Johannes W.; Zink, Angela; Aletaha, Daniel; Schoneveld, Leonard; Riel, Piet van; Gutermann, Loriane; Prior, Yeliz; Nikiphorou, Elena; Ferraccioli, Gianfranco; Schett, Georg; Hyrich, Kimme L.; Mueller,-Ladner, Ulf; Buch, Maya H.; McInnes, Iain B.; Heijde, Désirée van der; Laar, Jacob M. vanTétel Szabadon hozzáférhető EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis(2022) Nagy, György; Roodenrijs, Nadia M. T.; Welsing, Paco M. J.; Kedves, Melinda; Hamar, Attila Béla; van der Goes, Marlies C.; Kent, Alison; Bakkers, Margôt; Pchelnikova, Polina; Blaas, Etienne; Senolt, Ladislav; Szekanecz, Zoltán; Choy, Ernest; Dougados, Maxime; Jacobs, Johannes W. G.; Geenen, Rinie; Bijlsma, Johannes W.; Zink, Angela; Aletaha, Daniel; Schoneveld, Leonard; van Riel, Piet; Dumas, Sophie; Prior, Yeliz; Nikiphorou, Elena; Ferraccioli, Gianfranco; Schett, Georg; Hyrich, Kimme L.; Mueller,-Ladner, Ulf; Buch, Maya H.; McInnes, Iain B.; van der Heijde, Désirée; van Laar, Jacob M.Tétel Szabadon hozzáférhető Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme(2023) Dougados, Maxime; Charles-Schoeman, Christina; Szekanecz, Zoltán; Giles, Jon T.; Ytterberg, Steven R.; Bhatt, Deepak L.; Koch, Gary G.; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Connell, Carol A.; Yndestad, Arne; Rivas, Jose L.; Buch, Maya H.Tétel Szabadon hozzáférhető Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance(2022) Charles-Schoeman, Christina; Buch, Maya H.; Dougados, Maxime; Bhatt, Deepak L.; Giles, Jon T.; Ytterberg, Steven R.; Koch, Gary G.; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Rivas, Jose L.; Yndestad, Arne; Connell, Carol A.; Szekanecz, ZoltánTétel Szabadon hozzáférhető Systematic literature review and meta-analysis informing the EULAR Points to Consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer(2025) Sebbag, Eden; Molina-Collada, Juan; Ndoye, Ramatoulaye; Aletaha, Daniel; Askling, Johan; Gente, Karolina; Bertheussen, Heidi; Bitoun, Samuel; Bolek, Ertugrul Cagri; Buch, Maya H.; Burmester, Gerd R.; Canhão, Helena M.; Chatzidionysiou, Katerina; Curtis, Jeffrey R.; Danlos, Francois-Xavier; Guimarães, Vera; Hetland, Merete Lund; Iannone, Florenzo; Kostine, Marie; Kragstrup, Tue Wenzel; Kvien, Tore K.; Regierer, Anne Constanze; Schulze-Koops, Hendrik; Sedmak, Nathanaël; Silva-Fernández, Lucía; Szekanecz, Zoltán; Lauper, Kim; Finckh, Axel; Gottenberg, Jacques-Eric